Citichem India (544324)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Sales growth of 504.79% and profit growth of 466.67% show strong recent momentum, albeit from a low base.
• P/E of 6.84 with a ₹12 Cr market cap and ₹1 Cr latest-quarter profit suggests cheap valuation if earnings are sustainable.
• Piotroski F-Score of 7/9 points to improving financial health and operational fundamentals.
• ROCE of 11.56% indicates a reasonable return on capital employed.
• PEG of 0.01 implies the market is assigning almost no value to the reported growth.

Concerns

• Chemical trading is a low-moat, commoditized business with limited pricing power and customer loyalty.
• The 10% net margin (₹1 Cr profit on ₹10 Cr sales) is unusually high for a trading business and may not be sustainable.
• Zero dividend and promoter holding not disclosed leave shareholders without clarity on capital return and promoter alignment.
• Growth rates are from a tiny base and could be volatile; the trailing P/E and latest-quarter run-rate discrepancy needs explanation.

AI Analysis

I start with a simple question: do I understand how Citichem India makes money? It trades chemicals. That is a business where customers can leave for the next cheapest supplier; there is little pricing power and no durable moat. The figures scream growth: sales up 504.79%, profit up 466.67%, and a P/E of only 6.84. At a ₹12 Cr market cap, the latest quarter's ₹1 Cr profit suggests that if that quarterly pace were repeatable, the stock is absurdly cheap. But 'if' is the whole game. A 10% net margin for a chemical trader looks too good to accept at face value; I would want to know whether this is a one-off, an inventory gain, or something structural. The PEG ratio of 0.01 is mathematically saying the market is paying almost nothing for growth—usually that means the market is skeptical, not stupid. The Piotroski F-Score of 7/9 is a point in management's favor, and ROCE of 11.56% means capital is being employed sensibly, but a trading business can look wonderful for a year and then give it all back. I am also uncomfortable with zero dividend and missing promoter data. Without knowing how much skin the promoters own, I cannot judge alignment. Graham would say this is a statistical bargain if the numbers are real; Buffett would say a bargain in a lemon is not a bargain. I need a few more quarters of proof and an honest reading of margins before I trust this growth. Price alone will not make me act.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer